Venugopal Vangala

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Cancer Stem Cells

Endoplasmic Reticulum Stress

Top Venues

Molecules (Basel, Switzerland)

Molecular pharmaceutics

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Raghavendra Gowda, Asif Raza, Venugopal Vangala, Nazir Ahmad Lone, Jyh Ming Lin, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Todd D Schell, Gavin P Robertson, Shantu Amin, Arun K Sharma
Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor. Molecules (Basel, Switzerland) 29 (13) (2024)
Raghavendra Gowda, Asif Raza, Venugopal Vangala, Nazir Ahmad Lone, Jyh Ming Lin, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Todd D Schell, Gavin P Robertson, Shantu Amin, Arun K Sharma
Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor. Molecules (Basel, Switzerland) 29 (13) (2024)
Raghavendra Gowda, Asif Raza, Venugopal Vangala, Nazir Ahmad Lone, Jyh Ming Lin, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Todd D Schell, Gavin P Robertson, Shantu Amin, Arun K Sharma
Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor. Molecules (Basel, Switzerland) 29 (13) (2024)
Yarra Venkatesh, Venugopal Vangala, Rakesh Mengji, Amrita Chaudhuri, Sayantan Bhattacharya, Prasanta Kumar Datta, Rajkumar Banerjee, Avijit Jana, N D Pradeep Singh
One- and Two-Photon Uncaging of Carbon Monoxide (CO) with Real-Time Monitoring: On-Demand Carbazole-Based Dual CO-Releasing Platform to Test over Single and Combinatorial Approaches for the Efficient Regression of Orthotopic Murine Melanoma In Vivo . Journal of medicinal chemistry 65 (3) (2022)
Venugopal Vangala, Narendra Varma Nimmu, Sara Khalid, Madhusudana Kuncha, Ramakrishna Sistla, Rajkumar Banerjee, Arabinda Chaudhuri
Combating Glioblastoma by Codelivering the Small-Molecule Inhibitor of STAT3 and STAT3siRNA with α5β1 Integrin Receptor-Selective Liposomes. Molecular pharmaceutics 17 (6) (2020)